Skip to main content
Clinical Trials/ISRCTN12805385
ISRCTN12805385
Active, not recruiting
未知

K Early Detection Initiative for pancreatic cancer (UK-EDI)

niversity of Liverpool0 sites2,500 target enrollmentFebruary 13, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
niversity of Liverpool
Enrollment
2500
Status
Active, not recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 13, 2020
End Date
March 31, 2024
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
niversity of Liverpool

Eligibility Criteria

Inclusion Criteria

  • 1\. Age \> \= 50 years at time of study entry
  • 2\. New\-onset diabetes (defined as HbA1C \> \= 48mmol/mol (6\.5%)) diagnosed within 6 months of study entry
  • 3\. Written informed consent obtained from the participant prior to performing any protocol\-related procedures
  • 4\. Participant is willing and able to comply with the protocol for the duration of the study including scheduled follow\-up visits

Exclusion Criteria

  • 1\. Diagnosis of pancreatic cancer within 5 years of study entry
  • 2\. Treatment for digestive or endocrine cancer within 5 years of study entry
  • 3\. Previous surgical resection of the pancreas
  • 4\. A known history of hyperglycaemia/pre\-diabetes (HbA1c: 42\-47 mmol/mol (5\.9% \- 6\.4%)) of greater than 3 years duration
  • 5\. Diagnosis of diabetes \> 6 months before study entry
  • 6\. Pregnancy
  • 7\. Condition preventing study investigation and follow\-up
  • 8\. Inability or incapacity to give informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials